FDA Inspection 1219032 — Lhoist North America of Tennessee, Inc.
The FDA completed an inspection of Lhoist North America of Tennessee, Inc. on September 27, 2023 in Ocala, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Ocala, FL (United States)